3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1
3
Phase 3
2
Phase 4
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
28
Myelodysplastic Syndromes
13
Leukemia
8
Recurrence
6
Melanoma
5
Leukemia, Myelomonocytic, Chronic
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
3
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Blast Crisis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Thrombocytopenia
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
1
Prostatic Neoplasms
1
Peripheral Blood Stem Cell Transplantation
1
Neuroectodermal Tumors, Primitive
1
Myeloproliferative Disorders
1
Myeloid Malignancies
1
Mesothelioma, Malignant
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Rituximab
55
Cyclophosphamide
41
Lenalidomide
25
Vincristine
23
Doxorubicin
22
Prednisone
21
Etoposide
16
ibrutinib
12
Gemcitabine
12
fludarabine phosphate
10
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Carboplatin
10
Bendamustine Hydrochloride
10
Ifosfamide
9
Filgrastim
8
polatuzumab vedotin
7
obinutuzumab
7
Oxaliplatin
7
Mycophenolic Acid
7
Methotrexate
6
Cyclosporine
6
venetoclax
5
tafasitamab
5
Vorinostat
5
Radiotherapy
5
R-CHOP protocol
5
Prednisolone
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Lymphoma, Large B-Cell, Diffuse
×
Decitabine
×
Clear all
NCT02951728
2020-03-11
DR-CHOP
Ruijin Hospital
Phase 1/2
Unknown
58 enrolled